arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 1/2023 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    First orexin receptor antagonist for insomnia: daridorexant (QUVIVIQ)

    Aldosterone antagonist finerenone (KERENDIA) for diabetic nephropathy

    THERAPY FROM A CRITICAL VIEWPOINT

    Chorthalidone or hydrochlorothiazide for hypertension – how to choose?

    IN BRIEF

    After 60 years: chlorthalidone now also available in a strength of 12.5 mg and as generic

    Coumarin anticoagulants superior to new oral anticoagulants in antiphospholipid syndrome
    free

    CURRENT ADR NETWORK REPORT

    Acute kidney injury with dapagliflozin (FORXIGA)

    SIDE EFFECTS

    Contact allergies and systemic adverse effects of tea tree oil

    Bivalent BioNTech COVID-19 vaccine: possible risk of stroke?

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!